The Austrian biotech Themis -- specializing in vaccines for infectious and insect-borne diseases -- has…
The Covid-19 pandemic began as a few scattered cases in China, but within months, the respiratory infection had swept the world. The years 2020 and 2021 turned into a rollercoaster ride for the world’s population, with millions of people dead, livelihoods destroyed, and movement between countries plummeting.
Despite the strained situation, academic researchers and biotech and pharma companies globally have come together to develop protective vaccines and treatments against Covid-19. While we still have a long road ahead before this pandemic is declared over, the life sciences industry is bringing us closer to this moment with every new discovery, trial result, and fundraise. Read on to learn about the latest research, investments, trends, and pipeline developments.
Editor's Picks for Covid-19
- Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines
- How can vaccines keep up with evolving Covid-19 variants?
- Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials
- Tracking Covid-19 Cases with Wastewater Testing
- Developing a Vaccine that Protects Against Covid-19 Variants
European Biotech Industry Report 2021: A Year of European Biotechnology
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations in the biotech and pharma industry.Go to Report
Latest Covid-19 Articles
Like many others, the biopharma industry has been shaken by the rapid rise of the…
The German biotech CureVac -- which is developing an mRNA vaccine against coronavirus -- has…